VP
Vikram Premkumar
Physician · Holy Name Medical Center
Credentials: · · · · · · ·
History
Research
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
Blood Cancer Journal · 2021 · First of 18 authors · 89 citations
Use of daratumumab in high risk multiple myeloma: A meta-analysis
eJHaem · 2020 · First of 4 authors · 21 citations
Venetoclax in Immunoglobulin Light Chain Amyloidosis: Is This the Beginning or the End?
Case report · Clinical Lymphoma · 2019 · First of 3 authors · 16 citations
4 papers
3 papers
- RC
2 papers
2 papers
- AG
1 paper
- BP
1 paper
1 paper
1 paper
